CJC-1295 CJC-1295 (with DAC) is a growth hormone-releasing hormone (GHRH) analog that extends the body's GH pulses
REASONS TO CONSIDER TAKING A GLP-1 RA Your clinician can help you decide if starting a GLP-1 RA is right for you
Data availability The data that support the findings of this study are available from the corresponding author, F.G., upon reasonable request
A few key players are AstraZeneca, Boehringer Ingelheim, D&D Pharmatech, Eli Lilly, Hanmi Pharmaceutical, Novo Nordisk, Pfizer, Roche, Sanofi, and Tonghua Dongbao Pharmaceutical
If you can create biomimetics and other types of peptide activity through diet, it gives food manufacturers a strong opportunity to explore this kind of innovation. Hannah Ackermann, vice president of marketing and nutrition affairs at ingredient company COMET, says there is a robust opportunity in this approach, but she cautions that supplements are not subject to the same regulations as food and will have to be pursued prudently
As enforcement looms, access to compounded versions will diminish, potentially leading to increased costs and limited availability for patients. However, the direct-to-consumer programs introduced by Novo Nordisk and Eli Lilly aim to bridge this gap by providing authentic, FDA-approved medications at more accessible price points